Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Outcomes after intervention for enteral nutrition in patients with amyotrophic lateral sclerosis in multidisciplinary clinics.

Autor: Fullam T; Department of Neurology, Brooke Army Medical Center, San Antonio, Texas, USA., Hunt SL; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA., Han M; Department of Neurology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Denesia J; Department of Neurology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Chandrashekhar S; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA., Jawdat O; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA., Piccione E; Department of Neurology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Fernandes JA; Department of Neurology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Statland J; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.

Publikováno v: Muscle & nerve [Muscle Nerve] 2024 Jul; Vol. 70 (1), pp. 94-100. Date of Electronic Publication: 2024 May 02.

STUDIO PRELIMINARE SULLA PRESENZA DI CRYPTOCOCCUS NEOFORMANS IN ALCUNI LUOGHI PUBBLICI DELLE CITTA DI MESSINA E REGGIO CALABRIA: ISOLAMENTO DA GUANO DI PICCIONE E TERRENO

Autor: Criseo, Giuseppe, Bolignano, G., Chindemi, G., Forestieri, F., Guerrisi, R.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1ff48ef61c6cd845ebb7af8cb8b0c0ae
http://hdl.handle.net/11570/1738136

17:10-17:20 LMWH-induced miRNA changes in peripheral blood mononuclear cells in pregnancies with unexplained recurrent pregnancy loss

Autor: Bruno, V., Amati, F., Ticconi, C., Riccio, S., Vancheri, C., Rizzacasa, Barbara, Splendiani, E., Ferretti, E., Ernerudh, J., Piccione, E., Pietropolli, A.

Publikováno v: In Journal of Reproductive Immunology August 2023 158

Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.

Autor: Leclercq-Cohen G; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Steinhoff N; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Albertí Servera L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Nassiri S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Danilin S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Piccione E; Oncology Biomarker Development, Genentech, San Francisco, California., Yángüez E; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Hüsser T; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Herter S; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Schmeing S; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Gerber P; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Schwalie P; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Sam J; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Briner S; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Jenni S; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Bianchi R; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Biehl M; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Cremasco F; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Apostolopoulou K; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Haegel H; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Klein C; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Umaña P; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Bacac M; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 01; Vol. 29 (21), pp. 4449-4463.